UNSPSC 51314353: Chlorpheniramine/phenylpropanolamine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE501. This VA Drug Class (RE501) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT.

UNSPSC 51314353 Chlorpheniramine/phenylpropanolamine/pyrilamine is a Commodity code, but recent state and local procurement activity under this code shows little relevance to the nominal product scope. The three most recent opportunities tagged to this code involve naloxone and safe drug deactivation systems, therapeutic pharmacy initiatives for direct-to-manufacturer prescriptions, and generic multi-source pharmaceuticals with over-the-counter products—none of which align with the specific antihistamine/decongestant combination the code nominally describes. State and local purchasing offices appear to use this code as a catch-all for pharmaceutical and drug-related products and services beyond its intended narrow scope, creating misalignment between the code definition and actual procurement intent.

The issuing bodies include a county health department (Seminole County, Florida), a state health and human services commission (Texas HHS), and a multistate cooperative purchasing alliance (MMCAP administered by the Minnesota Department of Administration). Recent opportunities span Florida, Texas, Minnesota, and Oregon through cooperative purchasing. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas HHS RFI (HHS0017013, due April 3, 2026) gathered market intelligence on direct-to-manufacturer prescription programs; and MMCAP's RFP (S1070000015802, due March 26, 2026) established multi-award contracts for generic pharmaceuticals and OTC products across participating jurisdictions. The code shows activity but signals a categorical mismatch that may obscure accurate tracking of antihistamine/decongestant procurement under the intended UNSPSC definition.